Literature DB >> 16522285

Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up.

Monique Y Boudreaux, Evelyn O Talbott, Kevin E Kip, Maria M Brooks, Selma F Witchel.   

Abstract

Women with polycystic ovary syndrome (PCOS) often develop type 2 diabetes mellitus (T2DM). To determine the magnitude of risk of developing T2DM among women with PCOS, development of T2DM was prospectively assessed among women who had T2DM (n = 97) and controls (n = 95) using Kaplan-Meier survival analysis and Cox proportional hazards modeling. The women with T2DM had higher baseline weight (body mass index, P < 0.01) and lower insulin sensitivity (homeostasis assessment model of insulin resistance, P < 0.01). The 8-year incidence rate among cases and controls was 13.4% and 5.8%, respectively (relative risk = 2.3). Obese cases had a fivefold risk of T2DM developing (P < 0.01) compared with age-adjusted obese controls, indicating significant interaction between PCOS and obesity to effect T2DM risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522285     DOI: 10.1007/s11892-006-0056-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  39 in total

1.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

Authors:  R L Hanson; R E Pratley; C Bogardus; K M Narayan; J M Roumain; G Imperatore; A Fagot-Campagna; D J Pettitt; P H Bennett; W C Knowler
Journal:  Am J Epidemiol       Date:  2000-01-15       Impact factor: 4.897

2.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

3.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

4.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

5.  Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

Authors:  R J Norman; L Masters; C R Milner; J X Wang; M J Davies
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

Review 6.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

7.  Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.

Authors:  V L Nelson; R S Legro; J F Strauss; J M McAllister
Journal:  Mol Endocrinol       Date:  1999-06

8.  Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

Authors:  G Howard; R Bergman; L E Wagenknecht; S M Haffner; P J Savage; M F Saad; A Laws; R B D'Agostino
Journal:  Ann Epidemiol       Date:  1998-08       Impact factor: 3.797

9.  Insulin resistance in nonobese patients with polycystic ovarian disease.

Authors:  R J Chang; R M Nakamura; H L Judd; S A Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

10.  Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism.

Authors:  R M dos Reis; M C Foss; M D de Moura; R A Ferriani; M F Silva de Sá
Journal:  Gynecol Endocrinol       Date:  1995-03       Impact factor: 2.260

View more
  32 in total

1.  Age at Onset of Metabolic Syndrome Among Women With and Without Polycystic Ovary Syndrome-Like Status.

Authors:  Qing Peng; Carrie A Karvonen-Gutierrez; John F Randolph; Bin Nan; Daniel McConnell; Siobán D Harlow
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

Review 2.  PCOS in adolescence and type 2 diabetes.

Authors:  Anne-Marie Carreau; Jean-Patrice Baillargeon
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

3.  Genetic Predisposition to Polycystic Ovary Syndrome, Postpartum Weight Reduction, and Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes.

Authors:  Tiange Wang; Junhong Leng; Nan Li; Aline Martins de Carvalho; Tao Huang; Yan Zheng; Weiqin Li; Huikun Liu; Leishen Wang; Gang Hu; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2015-10-02       Impact factor: 5.958

4.  High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.

Authors:  J Cai; C H Wu; Y Zhang; Y Y Wang; W D Xu; T C Lin; S X Li; L H Wang; J Zheng; Y Sun; W Liu; T Tao
Journal:  Int J Obes (Lond)       Date:  2017-05-10       Impact factor: 5.095

5.  Alterations in Glucose Effectiveness and Insulin Dynamics: Polycystic Ovary Syndrome or Body Mass Index.

Authors:  Patricia Vuguin; Aviva B Sopher; Hailey Roumimper; Vivian Chin; Miriam Silfen; Donald J McMahon; Ilene Fennoy; Sharon E Oberfield
Journal:  Horm Res Paediatr       Date:  2017-05-05       Impact factor: 2.852

Review 6.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

Review 7.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

8.  Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies.

Authors:  Panagiotis Anagnostis; Rodis D Paparodis; Julia K Bosdou; Christina Bothou; Djuro Macut; Dimitrios G Goulis; Sarantis Livadas
Journal:  Endocrine       Date:  2021-06-26       Impact factor: 3.633

Review 9.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

10.  Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome.

Authors:  Carley A Gomez-Meade; Gabriela Lopez-Mitnik; Sarah E Messiah; Kristopher L Arheart; Adriana Carrillo; Nestor de la Cruz-Muñoz
Journal:  World J Diabetes       Date:  2013-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.